HIGHLIGHTS
- who: Avni Gupta from the The CHORD trial`s priority population was patients with prediabetes receiving care at two PC clinics, the Manhattan campus of the VA NY Harbor Healthcare System (VA), and Bellevue Hospital Center (BH) of New York City`s municipal hospital system [5]Protocol details have been described previously [5]. This study was approved by the New York University Langone Health and the Veterans Affairs Institutional Review Boards and was registered with(NCT03006666) on, . Informed consent was obtained from all the participants in the study. All the procedures were followed in accordance with the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.